Glossary

I am a patient	Home Links Site Map Contact Us

What is PAH? How is PAH diagnosed? How is PAH treated? What is PAH in Systemic Sclerosis (SSc)? Assessing the severity of PAH Glossary Further information?	Glossary A B C D E F G H I J K L M N O P Q R S T U V W X Y Z A Anticoagulants Associated pulmonary arterial hypertension (APAH) Autoantibody C Calcium channel blockers Collagen Congenital heart disease Connective tissue disease (CTD) CT scan (Computerised Tomography) Cyanosis D Diffuse cutaneous systemic sclerosis (dcSSc) Diuretics Dyspnoea E Echocardiography or Doppler echocardiogram EEisenmenger’s Syndrome / Physiology Electrocardiogram (ECG) Endothelin (ET) Endothelin receptor antagonist (ERA) Endothelin receptors Endothelium Extracellular matrix F Familial pulmonary arterial hypertension (FPAH) Fibroblasts Fibrosis H Human immunodeficiency virus (HIV) Hypertrophy I Idiopathic pulmonary arterial hypertension (IPAH) Inflammation Interstitial lung disease Ischaemia L Limited cutaneous systemic sclerosis (LcSSc) N New York Heart Association (NYHA) Nitric oxide (NO) P Portal hypertension Primary pulmonary hypertension (PPH) Prostacyclin Prostanoids Pulmonary arterial hypertension (PAH) Pulmonary artery Pulmonary fibrosis R Remodelling Right heart catheterisation RRaynaud’s phenomenon S Scleroderma or Systemic Sclerosis Sleep Apnoea Syncope (fainting) Systemic lupus erythematosus (SLE) or Lupus T Telangiectases V Vascular remodelling Vasculopathy Vasoconstriction Vasodilation W WHO Functional Class

Home | Legal | Contact Us | Printer Friendly